Frank Holden Mose (Frank H Mose, Frank Mose, F H Mose)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 17

Top Topics

Randomized Controlled Trial

Chronic Kidney Disease

Top Venues

JMIR research protocols

Journal of the American Heart Association

Clinical kidney journal

Physiological reports

This page only lists publications with an associated author ORCID identifier.

Publications

Steffen Flindt Nielsen, Camilla Lundgreen Duus, Niels Henrik Buus, Jesper Nørgaard Bech, Frank Holden Mose
Effects of Empagliflozin in Type 2 Diabetes With and Without Chronic Kidney Disease and Nondiabetic Chronic Kidney Disease: Protocol for 3 Crossover Randomized Controlled Trials (SiRENA Project). JMIR research protocols 13 (2024)
Camilla Lundgreen Duus, Steffen Flindt Nielsen, Bodil Gade Hornstrup, Frank Holden Mose, Jesper Nørgaard Bech
Self-Performed Dietary Sodium Reduction and Blood Pressure in Patients With Essential Hypertension: A Randomized Clinical Trial. Journal of the American Heart Association 13 (12) (2024)
Steffen Flindt Nielsen, Camilla Lundgreen Duus, Niels Henrik Buus, Jesper Nørgaard Bech, Frank Holden Mose
Effects of Empagliflozin in Type 2 Diabetes With and Without Chronic Kidney Disease and Nondiabetic Chronic Kidney Disease: Protocol for 3 Crossover Randomized Controlled Trials (SiRENA Project). JMIR research protocols 13 (2024)
Camilla Lundgreen Duus, Steffen Flindt Nielsen, Bodil Gade Hornstrup, Frank Holden Mose, Jesper Nørgaard Bech
Self-Performed Dietary Sodium Reduction and Blood Pressure in Patients With Essential Hypertension: A Randomized Clinical Trial. Journal of the American Heart Association 13 (12) (2024)
Camilla Lundgreen Duus, Steffen Flindt Nielsen, Bodil Gade Hornstrup, Frank Holden Mose, Jesper Nørgaard Bech
Self-Performed Dietary Sodium Reduction and Blood Pressure in Patients With Essential Hypertension: A Randomized Clinical Trial. Journal of the American Heart Association 13 (12) (2024)
Marie Møller, Iain Bressendorff, Rikke Borg, Hans Dieperink, Jon W Gregersen, Helle Hansen, Kristine Hommel, Morten Baltzer Houlind, Per Ivarsen, Karina Haar Jensen, Morten B Jørgensen, Tilde Kristensen, Dorrit Krustrup, Frank Holden Mose, Ellen Burgess, Kjeld E Otte, Stephen C Bain, Kristine D Schandorff, Ditte Hansen
The validity of pathology codes for biopsy-confirmed kidney disease in the Danish National Patobank. Clinical kidney journal 17 (8) (2024)
Marie Møller, Iain Bressendorff, Rikke Borg, Hans Dieperink, Jon W Gregersen, Helle Hansen, Kristine Hommel, Morten Baltzer Houlind, Per Ivarsen, Karina Haar Jensen, Morten B Jørgensen, Tilde Kristensen, Dorrit Krustrup, Frank Holden Mose, Ellen Burgess, Kjeld E Otte, Stephen C Bain, Kristine D Schandorff, Ditte Hansen
The validity of pathology codes for biopsy-confirmed kidney disease in the Danish National Patobank. Clinical kidney journal 17 (8) (2024)
Camilla Lundgreen Duus, Steffen Flindt Nielsen, Bodil Gade Hornstrup, Frank Holden Mose, Jesper Nørgaard Bech
Self-Performed Dietary Sodium Reduction and Blood Pressure in Patients With Essential Hypertension: A Randomized Clinical Trial. Journal of the American Heart Association 13 (12) (2024)
Birgith Engelst Grove, Liv Marit Valen Schougaard, Frank Holden Mose, Else Randers, Niels Henrik Hjollund, Per Ivarsen, Annette de Thurah
Remote symptom monitoring with patient-reported outcome measures in outpatients with chronic kidney disease (PROKID): a multicentre randomised controlled non-inferiority study. Clinical kidney journal 17 (7) (2024)
Steffen Flindt Nielsen, Camilla Lundgreen Duus, Niels Henrik Buus, Jesper Nørgaard Bech, Frank Holden Mose
Effects of Empagliflozin in Type 2 Diabetes With and Without Chronic Kidney Disease and Nondiabetic Chronic Kidney Disease: Protocol for 3 Crossover Randomized Controlled Trials (SiRENA Project). JMIR research protocols 13 (2024)
Camilla Lundgreen Duus, Steffen Flindt Nielsen, Bodil Gade Hornstrup, Frank Holden Mose, Jesper Nørgaard Bech
Self-Performed Dietary Sodium Reduction and Blood Pressure in Patients With Essential Hypertension: A Randomized Clinical Trial. Journal of the American Heart Association (2024)
Steffen Flindt Nielsen, Camilla Lundgreen Duus, Niels Henrik Buus, Jesper Nørgaard Bech, Frank Holden Mose
Effects of Empagliflozin in Type 2 Diabetes With and Without Chronic Kidney Disease and Nondiabetic Chronic Kidney Disease: Protocol for 3 Crossover Randomized Controlled Trials (SiRENA Project). JMIR research protocols 13 (2024)
Birgith Engelst Grove, Liv Marit Valen Schougaard, Frank Holden Mose, Else Randers, Niels Henrik Hjollund, Per Ivarsen, Annette de Thurah
Remote symptom monitoring with patient-reported outcome measures in outpatients with chronic kidney disease (PROKID): a multicentre randomised controlled non-inferiority study. Clinical kidney journal 17 (7) (2024)
Steffen Flindt Nielsen, Camilla Lundgreen Duus, Niels Henrik Buus, Jesper Nørgaard Bech, Frank Holden Mose
Effects of Empagliflozin in Type 2 Diabetes With and Without Chronic Kidney Disease and Nondiabetic Chronic Kidney Disease: Protocol for 3 Crossover Randomized Controlled Trials (SiRENA Project). JMIR research protocols 13 (2024)
Frank Holden Mose, Henrik Birn, Nikolai Hoffmann-Petersen, Jesper N Bech
Prednisolone treatment in acute interstitial nephritis (PRAISE) - protocol for the randomized controlled trial. BMC nephrology 22 (1) (2021)
Frank Holden Mose, Anna Ewa Oczachowska-Kulik, Robert Andrew Fenton, Jesper Nørgaard Bech
Effect of furosemide on body composition and urinary proteins that mediate tubular sodium and sodium transport-A randomized controlled trial. Physiological reports 8 (24) (2021)
M H Malmberg, Frank Holden Mose, E B Pedersen, Jesper Nørgaard Bech
A Comparison of Urine Dilution Ability between Adult Dominant Polycystic Kidney Disease, Other Chronic Kidney Diseases, and Healthy Control Subjects: A Case-Control Study. International journal of nephrology 2020 (2020)